Access the full text.
Sign up today, get DeepDyve free for 14 days.
Ophthalmology, 102
NL (1999)
Pathophysiology and hemodynamics of branch retinal vein occlusionOphthalmology, 106
Aiello (1994)
Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disordersN Engl J Med, 331
Russo (2009)
Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusionRetina, 29
Scott (2012)
Baseline characteristics and response to treatment of participants with hemiretinal compared with branch retinal or central retinal vein occlusion in the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study: SCORE study report 14Arch Ophthalmol, 130
Klein (2008)
The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye StudyArch Ophthalmol, 126
Ophthalmology, 102
Iliev (2006)
Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucomaAm J Ophthalmol, 142
Hayreh (1994)
Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristicsAm J Ophthalmol, 117
Spaide (2013)
Prospective study of peripheral panretinal photocoagulation of areas of nonperfusion in central retinal vein occlusionRetina, 33
Wykoff (2017)
Peripheral laser for recalcitrant macular edema owing to retinal vein occlusion: the WAVE trialOphthalmology, 124
Yen (2013)
Risk of retinal vein occlusion in patients with systemic lupus erythematosus: a population-based cohort studyBr J Ophthalmol, 97
Chou (2012)
Sleep apnea and risk of retinal vein occlusion: a nationwide population-based study of Taiwanese.Am J Ophthalmol, 154
Haller (2011)
Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study resultsOphthalmology, 118
Ogura (2014)
Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO studyAm J Ophthalmol, 158
Heier (2012)
Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trialOphthalmology, 119
Feltgen (2007)
Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot studyOphthalmology, 114
McAllister (2010)
The Central Retinal Vein Bypass Study: a trial of laser-induced chorioretinal venous anastomosis for central retinal vein occlusionOphthalmology, 117
Campochiaro (2011)
Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III studyOphthalmology, 118
Hayreh (2004)
Intraocular pressure abnormalities associated with central and hemicentral retinal vein occlusionOphthalmology, 111
Heier (2014)
Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS study.Ophthalmology, 121
O'Mahoney (2008)
Retinal vein occlusion and traditional risk factors for atherosclerosisArch Ophthalmol, 126
Funk (2009)
Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumabInvest Ophthalmol Vis Sci, 50
Lahey (2002)
Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of ageOphthalmology, 109
Fekrat (1999)
Chorioretinal venous anastomosis for central retinal vein occlusion: transvitreal venipuncture.Ophthalmic Surg Lasers, 30
AC (1993)
Central retinal vein occlusion in young adultsSurv Ophthalmol, 37
Rogers (2010)
The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia.Ophthalmology, 117
Arch Ophthalmol, 104
Haller (2010)
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.Ophthalmology, 117
Hayreh (2005)
Prevalent misconceptions about acute retinal vascular occlusive disordersProg Retin Eye Res, 24
Scott (2009)
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 6Arch Ophthalmol, 127
Campochiaro (2015)
Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT studyOphthalmology, 122
Tsui (2011)
Ischemic index and neovascularization in central retinal vein occlusionRetina, 31
Epstein (2012)
Benefit from bevacizumab for macular edema in central retinal vein occlusion: twelve-month results of a prospective, randomized studyOphthalmology, 119
Scott (2017)
Effect of bevacizumab vs aflibercept on visual acuity among patients with macular edema due to central retinal vein occlusion: the SCORE2 randomized clinical trialJAMA, 317
Am J Ophthalmol, 116
Glacet-Bernard (2010)
Obstructive sleep apnea among patients with retinal vein occlusionArch Ophthalmol, 128
Spaide (2011)
Peripheral areas of nonperfusion in treated central retinal vein occlusion as imaged by wide-field fluorescein angiographyRetina, 31
Campochiaro (2015)
Scatter photocoagulation does not reduce macular edema or treatment burden in patients with retinal vein occlusion: the RELATE trialOphthalmology, 122
Ehlers (2011)
Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusionRetina, 31
Brown (2010)
Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study.Ophthalmology, 117
Arch Ophthalmol, 115
McAllister (2014)
The effect of central retinal venous pressure in patients with central retinal vein occlusion and a high mean area of nonperfusionOphthalmology, 121
Arevalo (2008)
Radial optic neurotomy for central retinal vein occlusion: results of the Pan-American Collaborative Retina Study Group (PACORES)Retina, 28
Downloaded from http://journals.lww.com/apjoo by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/03/2020 REVIEW ARTICLE Michael Ip, MD,* and Andrew Hendrick, MD† groups had increased risk of BRVO compared with white popu‑ Abstract: Retinal vein occlusions are a very common condition with lations, with no detectable difference by ethnicity in individuals great importance in ophthalmology clinical practice. This article reviews with CRVO. In the Beaver Dam Eye Study, the cumulative inci‑ the salient epidemiology, risk factors, clinical features, and treatments dence of BRVO at 15 years was 1.8%, whereas cumulative inci‑ related to retinal vein occlusions. 4 dence of CRVO was 0.5% at 15 years. The greatest predicator of developing RVO is a RVO in the contralateral eye. Individuals Key Words: retinal vein occlusion, macular edema, neovascularization with BRVO in 1 eye have a 10% risk of any RVO in the contra‑ lateral eye within 3 years. The estimated risk of contralateral in‑ (Asia-Pac J Ophthalmol 2018;7:40–45) volvement in people with CRVO is ~1% per year, which increases 5,6 to 7% at 5 years. Typical atherosclerosis risk factors are commonly associated etinal vein occlusions (RVO) are a heterogeneous group of with all types of RVO, but vein occlusions can also be second‑ Rdisorders that have
The Asia-Pacific Journal of Ophthalmology – Wolters Kluwer Health
Published: Jan 1, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.